ACT-660602 is an orally active chemokine receptor CXCR3 antagonist (IC50: 204 nM) that inhibits T cell migration and has demonstrated significant efficacy in an in vivo model of acute lung injury. It is useful for studying autoimmune diseases.
Molekulargewicht:
534.48
CAS Nummer:
[1646267-59-5]
Formel:
C20H20F6N8OS
Target-Kategorie:
CXCR|||Others
T63761
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten